ArticleJTCVS open2025

Safety and efficacy of empagliflozin in heart failure among patients with a history of valvular heart disease: Insights from EMPEROR-Pooled.

Nitish K Dhingra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.